Yasuo Nakagishi

Interleukin-18 for predicting the development of macrophage activation syndrome in systemic juvenile idiopathic arthritis

Masaki Shimizu, Yasuo Nakagishi, Natsumi Inoue et al. · Clinical Immunology · 2015 · 167 citations

Inflammation, Rheumatology, Cytokine +12

Distinct subsets of patients with systemic juvenile idiopathic arthritis based on their cytokine profiles

Masaki Shimizu, Yasuo Nakagishi, Akihiro Yachie · Cytokine · 2012 · 129 citations

Inflammation, Rheumatology, Rheumatoid Disorder +14

Tocilizumab masks the clinical symptoms of systemic juvenile idiopathic arthritis-associated macrophage activation syndrome: The diagnostic significance of interleukin-18 and interleukin-6

Masaki Shimizu, Yasuo Nakagishi, Kazuko Kasai et al. · Cytokine · 2012 · 127 citations

Inflammation, Rheumatology, Clinical Symptoms +11

Clinical significance of serum CXCL9 levels as a biomarker for systemic juvenile idiopathic arthritis associated macrophage activation syndrome

Mao Mizuta, Masaki Shimizu, Natsumi Inoue et al. · Cytokine · 2019 · 52 citations

Inflammation, Rheumatology, Rheumatoid Disorder +13

Tocilizumab modifies clinical and laboratory features of macrophage activation syndrome complicating systemic juvenile idiopathic arthritis

Masaki Shimizu, Mao Mizuta, Nami Okamoto et al. · Pediatric Rheumatology · 2020 · 46 citations · Full text